Ron Philip

Ron Philip is the President & Chief Executive Officer at Orbital Therapeutics. With more than 30 years of experience across biopharma companies and management consulting, Mr. Philip is a proven leader with extensive experience in building companies, leading organizational growth, and guiding teams through the development of novel therapies. Prior to joining Orbital, Mr. Philip served as the Chief Executive Officer of Spark Therapeutics where he led the company through the commercial launch of the first approved gene therapy for a genetic disease, LUXTURNA®.